siponimod (Mayzent) Last Updated: February 19, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: siponimod Indications: Secondary progressive multiple sclerosis Brand Name: MayzentManufacturer: Novartis Pharmaceuticals Canada Inc.Project Number: SR0631-000Project Status: ActiveSubmission Type: New Details
brolucizumab (TBC) Last Updated: February 20, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: brolucizumab Indications: Macular degeneration, age-related Brand Name: TBCManufacturer: Novartis Pharmaceuticals Canada Inc.Project Number: SR0632-000Project Status: ActiveSubmission Type: New Details
vedolizumab (Entyvio ) Last Updated: February 19, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: vedolizumab Indications: Ulcerative Colitis Brand Name: Entyvio Manufacturer: Takeda Canada Inc.Project Number: SR0635-000 Project Status: ActiveSubmission Type: New Details
vortioxetine hydrobromide (Trintellix ) Last Updated: February 20, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: vortioxetine hydrobromide Indications: Major depressive disorder (MDD), adults. Brand Name: Trintellix Manufacturer: Lundbeck Canada Inc.Project Number: SR0611-000Project Status: ActiveSubmission Type: New Details
glucagon (Baqsimi) Last Updated: February 20, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: glucagon Indications: Severe hypoglycemic reactions Brand Name: BaqsimiManufacturer: Eli Lilly Canada Inc.Project Number: SR0626-000Project Status: ActiveSubmission Type: New Details
sodium zirconium cyclosilicate (Lokelma) Last Updated: February 3, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: sodium zirconium cyclosilicate Indications: Hyperkalemia, adults Brand Name: LokelmaManufacturer: AstraZeneca Canada Inc. Project Number: SR0612-000Project Status: ActiveSubmission Type: New Details
tafamidis (Vyndaqel) Last Updated: February 21, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: tafamidis Indications: transthyretin-mediated amyloidosis Brand Name: VyndaqelManufacturer: Pfizer CanadaProject Number: SR0625-000Project Status: ActiveSubmission Type: New Details
etonogestrel (TBC) Last Updated: February 20, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: etonogestrel Indications: Prevention of pregnancy Brand Name: TBCManufacturer: Merck Canada Inc.Project Number: SR0629-000Project Status: WithdrawnSubmission Type: New Details
caplacizumab (Cablivi) Last Updated: February 19, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: caplacizumab Indications: Acquired thrombotic thrombocytopenic purpura (aTTP) Brand Name: CabliviManufacturer: Sanofi-Genzyme, a division of sanofi-aventis Canada Inc.Project Number: SR0633-000Project Status: ActiveSubmission Type: New Details
ixekizumab (Taltz ) Last Updated: February 19, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: ixekizumab Indications: Ankylosing spondylitis Brand Name: Taltz Manufacturer: Eli Lilly Canada Inc.Project Number: SR0630-000Project Status: ActiveSubmission Type: New Indication Details
